BioVentrix Revenue and Competitors
Estimated Revenue & Valuation
- BioVentrix's estimated annual revenue is currently $3M per year.
- BioVentrix's estimated revenue per employee is $125,500
- BioVentrix's total funding is $180.7M.
Employee Data
- BioVentrix has 24 Employees.
- BioVentrix grew their employee count by -44% last year.
BioVentrix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is BioVentrix?
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches. BioVentrix offers benefits to all stakeholders in heart failure: Patient improved survival and QOL by treating the underlying cause of HF less invasively Payor reduced hospitalizations and avoidance of more expensive, highly invasive procedures like transplant and LVAD Provider become a pioneer in heart failure and offer unique solutions to your patients, in the growing and most expensive disease state in the world
keywords:Biotechnology
$180.7M
Total Funding
24
Number of Employees
$3M
Revenue (est)
-44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioVentrix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Director, Clinical Affairs & Operations | Reveal Email/Phone |
2 | Manager, Therapy Development for the ALIVE Trial,Southeast Region | Reveal Email/Phone |
3 | Senior Director, Principal Science & Cardiac Imaging | Reveal Email/Phone |
4 | Director QA | Reveal Email/Phone |
5 | Clinical Specialist | Reveal Email/Phone |
6 | Chief Operating Officer | Reveal Email/Phone |
7 | R&D Engineer | Reveal Email/Phone |
8 | VP Sales, US | Reveal Email/Phone |
9 | President & CEO | Reveal Email/Phone |
10 | Manufacturing Operations Manager | Reveal Email/Phone |
BioVentrix News
MASSDEVICE ON CALL — BioVentrix reported a $12.4 million funding round for its Revivent heart failure treatment. San Ramon, Calif.-based BioVentrix said in an equity filing that the equity round, involving 195 unnamed investors, began Jan. 24 and closed today. The company will net about $11.4 ...
BioVentrix is now trying to effect the same left ventricle functional improvement using an endovascular, transcatheter approach. The company’s board of directors includes Steven Healy, president of Zimmer Spine. Here’s a video of the Revivent Myocardial Anchoring System: Promoted Clinical Ca ...
Other Companies in San Ramon
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.4M | 24 | 4% | N/A |
#2 | $3.4M | 24 | N/A | N/A |
#3 | $2.4M | 24 | 0% | N/A |
#4 | $2.5M | 25 | 9% | N/A |
#5 | $4.3M | 25 | 4% | N/A |